title: [Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) for metastatic liver tumors in patients with gastric cancer].
abstract: We reviewed the effects and complications of transcatheter arterial chemoembolization (TACE), using degradable starch microspheres (DSM) in eight patients with hepatic metastases from gastric cancer. The rate of complete remission (CR) +partial remission (PR) was 62.5%, and the actual survival rates at one and two years post-treatment were 87.5%, and 52.5% respectively. The median survival time was 36.1 months. Almost all side effects were acceptable but in one case, we observed liver abscess. From this study, we suggest that DSM-TACE might be a safe and effective multimodal treatment for metastatic liver tumors in patients with gastric cancer.
authors.affiliation: Department of Gastroenterology, Cancer Institute Ariake Hospital.
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Hirasawa
authors.forename: Shingo
authors.initials: S
authors.lastname: Asahara
authors.forename: Satoshi
authors.initials: S
authors.lastname: Fujisaki
authors.forename: Kensuke
authors.initials: K
authors.lastname: Kuraoka
authors.forename: Kouichi
authors.initials: K
authors.lastname: Takano
authors.forename: Akira
authors.initials: A
authors.lastname: Kamei
authors.forename: Takaaki
authors.initials: T
authors.lastname: Ikari
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D003131:Combined Modality Therapy; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary* / Q000628:therapy*; D008297:Male; D008863:Microspheres; D008875:Middle Aged; D012189:Retrospective Studies; D013213:Starch; D013274:Stomach Neoplasms / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D013213:Starch